Vendozisp. z o.o.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2022-06-14
Share capital
15 000,00 PLN
Activity description

Vendozi provides a platform for laboratory and imaging diagnostics in clinical trials, covering more than 1,500 specialized laboratory tests, a full range of CT, MR and PET-CT scans, over 1,300 specimen collection points, and more than 1,000 imaging facilities. The platform supports examination commissioning, secure result access through PACS and HL7 integration, configurable reporting, and consolidated monthly invoicing.

Registered address
ul. Rezedowa 10, 60-184 Poznań, Poland
Website
vendozi.comWebsite active
Email
Email warning
Phone
Electronic delivery address
AE:PL-36257-61124-JIBEA-23

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 919.66kMedianUSD 91.91kAverageUSD 1.53m
Net profit
This companyUSD 162.06kMedianUSD 2.48kAverageUSD 176.57k
Operating costs
This companyUSD 750.10kMedianUSD 83.36kAverageUSD 1.29m
Assets
This companyUSD 376.80kMedianUSD 40.43kAverageUSD 1.14m

Bank accounts

Registered as a VAT taxpayer on 2022-07-20. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Michał Jerzy Harasymczuk – President of the Management Board
Michał Kwiatek – Vice President of the Management Board

Manner of representation

The company may be represented by: a) in the case of a two-member management board – each member of the management board independently, b) in the case of a three-member management board – two members of the management board acting jointly.

Ownership

OwnerSharesShare valueStake
Michał Jerzy Harasymczuk (38)
150$4,051.86100%

Beneficial owners

Person

Subsidiaries

NameStake
Neoinsightsp. z o.o.
100%

Change history

DateEvent
2025-02-13Share capital change
2023-02-24Share capital change
2022-11-29Share capital change
2022-06-14Entered in the register

FAQ

Last updated: 2026-10-07